McKesson Co. (NYSE:MCK) – Analysts at Leerink Swann upped their FY2019 EPS estimates for McKesson in a research report issued to clients and investors on Thursday, June 28th. Leerink Swann analyst D. Larsen now anticipates that the company will post earnings per share of $13.40 for the year, up from their prior forecast of $13.30. Leerink Swann has a “Market Perform” rating and a $160.00 price objective on the stock. Leerink Swann also issued estimates for McKesson’s FY2020 earnings at $14.44 EPS.
Get McKesson alerts:McKesson (NYSE:MCK) last released its earnings results on Thursday, May 24th. The company reported $3.49 EPS for the quarter, missing the consensus estimate of $3.56 by ($0.07). McKesson had a net margin of 0.03% and a return on equity of 23.55%. The firm had revenue of $51.63 billion during the quarter, compared to the consensus estimate of $51.36 billion. During the same period in the prior year, the business earned $3.41 earnings per share. McKesson’s quarterly revenue was up 6.0% compared to the same quarter last year.
Several other equities analysts have also commented on MCK. Royal Bank of Canada decreased their target price on shares of McKesson to $158.00 and set a “market perform” rating on the stock in a report on Friday. ValuEngine lowered shares of McKesson from a “sell” rating to a “strong sell” rating in a report on Saturday, June 2nd. Barclays initiated coverage on shares of McKesson in a report on Thursday, March 8th. They issued an “equal weight” rating and a $165.00 target price on the stock. Finally, Bank of America decreased their price target on shares of McKesson from $179.00 to $172.00 and set a “buy” rating on the stock in a report on Wednesday, April 11th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $174.70.
McKesson opened at $133.40 on Monday, Marketbeat Ratings reports. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.57 and a current ratio of 1.01. McKesson has a 12 month low of $131.43 and a 12 month high of $178.86. The stock has a market capitalization of $26.92 billion, a price-to-earnings ratio of 10.57, a PEG ratio of 1.25 and a beta of 1.26.
The business also recently declared a quarterly dividend, which will be paid on Monday, July 2nd. Investors of record on Friday, June 1st will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.02%. The ex-dividend date is Thursday, May 31st. McKesson’s dividend payout ratio (DPR) is presently 10.78%.
In related news, SVP Erin M. Lampert sold 868 shares of McKesson stock in a transaction that occurred on Wednesday, May 30th. The shares were sold at an average price of $142.00, for a total transaction of $123,256.00. Following the sale, the senior vice president now directly owns 64 shares of the company’s stock, valued at approximately $9,088. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.87% of the company’s stock.
A number of large investors have recently bought and sold shares of the stock. Boston Partners boosted its position in McKesson by 122.4% during the 1st quarter. Boston Partners now owns 4,036,373 shares of the company’s stock worth $568,604,000 after buying an additional 2,221,241 shares during the period. Vulcan Value Partners LLC boosted its position in McKesson by 9.2% during the 4th quarter. Vulcan Value Partners LLC now owns 3,612,389 shares of the company’s stock worth $563,352,000 after buying an additional 305,492 shares during the period. Pzena Investment Management LLC boosted its position in McKesson by 1.4% during the 1st quarter. Pzena Investment Management LLC now owns 2,635,648 shares of the company’s stock worth $371,284,000 after buying an additional 35,247 shares during the period. Alliancebernstein L.P. boosted its position in McKesson by 1.5% during the 4th quarter. Alliancebernstein L.P. now owns 2,450,313 shares of the company’s stock worth $382,126,000 after buying an additional 37,023 shares during the period. Finally, Geode Capital Management LLC boosted its position in McKesson by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 2,270,865 shares of the company’s stock worth $353,418,000 after buying an additional 12,150 shares during the period. Institutional investors and hedge funds own 90.17% of the company’s stock.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
No comments:
Post a Comment